Exercise Prescriptions for Patients With Cardiovascular Disease

Cardiovascular Diseases Clinical Trial

Official title:

Are Exercise Prescriptions for Patients With Cardiovascular Disease, Made by Physiotherapists, in Agreement With International Guidelines?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05449652
• Other study ID #: AXXON
• Status: Completed
• Start date: February 16, 2022
• Est. completion date: April 30, 2022

Study information

• Verified date: July 2022
• Source: Hasselt University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Physiotherapists are often confronted with patients with (elevated risk for) cardiovascular disease (CVD), even when this is not the primary indication for physiotherapy. Hence, physiotherapists should be able to provide evidence-based exercise advice to these patients, but this has not been assessed. The aim of this study was therefore to assess whether exercise prescriptions by physiotherapists to patients with CVD are in accordance with international recommendations.

Description:

In this prospective observational survey, forty-seven Belgian physiotherapists agreed to prescribe exercise intensity, frequency, session duration, program duration, and exercise type (endurance or strength training) for the same three patient cases. Exercise prescriptions were compared between clinicians and relations with clinician characteristics were studied. In addition, the agreement between physiotherapists' exercise prescriptions and those from international recommendations (based on a maximal score of 60/per case) was assessed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 47
• Est. completion date: April 30, 2022
• Est. primary completion date: April 30, 2022
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria: Currently professionally active Flemish physiotherapists Exclusion Criteria: Not having access to a device that allows the use of the EXercise Prescription in Everyday practice & Rehabilitative Training (EXPERT) tool.

Related Conditions & MeSH terms

• Cardiovascular Diseases

Intervention

Other:
• To prescribe exercise prescription for CVD patients
To prescribe exercise intensity, frequency, session duration, program duration, and exercise type (endurance or strength training) for the same three patient cases

Locations

Country	Name	City	State
Belgium	Hasselt University	Diepenbeek	Limburg

Sponsors (1)

Lead Sponsor	Collaborator
Hasselt University

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Exercise intensity	Assessment of the prescription of exercise intensity (expressed in heart rate in beats per minute)	February - April 2022
Primary	Exercise frequency	Assessment of exercise frequency (expressed in number of exercise sessions per week)	February - April 2022
Primary	Session duration	Assessment of session duration (expressed in number of minutes)	February - April 2022
Primary	Program duration	Assessment of program duration (expressed in number of weeks)	February - April 2022
Primary	Exercise type	Aerobic exercise or strength exercise	February - April 2022
Primary	Total exercise volume	Multiplication of number of prescribed weeks, number of prescribed sessions/week, prescribed individual session duration and prescribed exercise intensity	February - April 2022
Secondary	Association between exercise prescriptions and clinician characteristics'	Relations between exercise prescriptions (intensity, frequency, session/program duration, exercise type) and clinician characteristics (age, gender, education, experience,...) were studied.	February - April 2022